Lung cancer (Amsterdam, Netherlands), 2016-10, Vol.100, p.30-37
- Ardizzoni, Andrea
- Tiseo, Marcello
- Boni, Luca
- di Maio, Massimo
- Buffoni, Lucio
- Belvedere, Ornella
- Grossi, Francesco
- D'Alessandro, Vito
- de Marinis, Filippo
- Barbera, Santi
- Caroti, Cinzia
- Favaretto, Adolfo
- Cortinovis, Diego
- Morrica, Brunello
- Tixi, Lucia
- Ceschia, Tino
- Parisi, Salvatore
- Ricardi, Umberto
- Grimaldi, Andrea
- Loreggian, Lucio
- Navarria, Pierina
- Huber, Rudolf M
- Belani, Chandra
- Bruswig, Paal Fr
- Scagliotti, Giorgio Vittorio
- Scolaro, Tindaro
2016
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Ardizzoni, Andrea
- Tiseo, Marcello
- Boni, Luca
- di Maio, Massimo
- Buffoni, Lucio
- Belvedere, Ornella
- Grossi, Francesco
- D'Alessandro, Vito
- de Marinis, Filippo
- Barbera, Santi
- Caroti, Cinzia
- Favaretto, Adolfo
- Cortinovis, Diego
- Morrica, Brunello
- Tixi, Lucia
- Ceschia, Tino
- Parisi, Salvatore
- Ricardi, Umberto
- Grimaldi, Andrea
- Loreggian, Lucio
- Navarria, Pierina
- Huber, Rudolf M
- Belani, Chandra
- Bruswig, Paal Fr
- Scagliotti, Giorgio Vittorio
- Scolaro, Tindaro
- Titel
- Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLC
- Ist Teil von
- Lung cancer (Amsterdam, Netherlands), 2016-10, Vol.100, p.30-37
- Ort / Verlag
- Ireland: Elsevier B.V
- Erscheinungsjahr
- 2016
- Quelle
- Elsevier ScienceDirect Journals
- Beschreibungen/Notizen
- Highlights • Chemo-radiotherapy is standard of care in the unresectable stage III NSCLC. • We performed a multicenter phase III trial and a literature-based meta-analysis. • Addition of taxane to thoracic radiotherapy after induction chemotherapy was studied. • The results do not support a clinically meaningful benefit on survival
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0169-5002eISSN: 1872-8332DOI: 10.1016/j.lungcan.2016.07.026Titel-ID: cdi_crossref_primary_10_1016_j_lungcan_2016_07_026
- Format
- –
- Schlagworte
- Adult, Aged, Antineoplastic Agents - administration & dosage, Antineoplastic Agents - therapeutic use, Antineoplastic Combined Chemotherapy Protocols - therapeutic use, Bridged-Ring Compounds - administration & dosage, Bridged-Ring Compounds - therapeutic use, Carboplatin - administration & dosage, Carboplatin - therapeutic use, Carcinoma, Non-Small-Cell Lung - drug therapy, Carcinoma, Non-Small-Cell Lung - radiotherapy, Chemotherapy, Combined Modality Therapy - methods, Concurrent treatment, Female, Hematology, Oncology and Palliative Medicine, Humans, Induction Chemotherapy, Male, Meta-Analysis as Topic, Middle Aged, Neoplasm Staging, NSCLC, Paclitaxel - administration & dosage, Paclitaxel - therapeutic use, Pulmonary/Respiratory, Radiotherapy, Stage III, Survival Rate, Taxoids - administration & dosage, Taxoids - therapeutic use, Treatment Outcome